Table 4 Evaluation of pleiotropy and heterogeneity.
From: Protective effect of uridine on atrial fibrillation: a Mendelian randomisation study
Data source | Heterogeneity | Pleiotropy | ||
|---|---|---|---|---|
I2 (%) | Cochran’s Q p | MR-Egger intercept | MR-Egger intercept p | |
GWAS meta-analysis (Nielsen et al.) | 0 | 0.656 | 0.02 | 0.757 |
AF HRC | 0 | 0.433 | − 0.07 | 0.441 |
FinnGen | 76 | 0.017 | 0.04 | 0.934 |
